LivaNova PLC
LIVN
株式のランク
#3842
LivaNova PLC is a global medical technology company dedicated to developing,... LivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments. Its Cardiopulmonary division provides essential products for heart-lung procedures, such as oxygenators, heart-lung machines, and various perfusion systems. The Neuromodulation segment is known for its VNS Therapy System, an implantable device that delivers vagus nerve stimulation to treat drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. This segment is also advancing the VITARIA System, which employs VNS for heart failure, through clinical development. The Advanced Circulatory Support segment offers temporary life support solutions, including both cardiopulmonary and respiratory support technologies. LivaNova serves a wide range of medical professionals, including perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals and healthcare providers. The company's products are distributed globally through both its direct sales force and independent distributors. Additionally, LivaNova has a research collaboration with Verily aimed at discovering clinical biomarkers for depression. Founded in 1987, the company is headquartered in London, United Kingdom.
株価
$78.96
時価総額
$4.34B
変化（1日）
-0.94%
変化（1年）
44.32%
国
GB
取引 LivaNova PLC (LIVN)
カテゴリー
Healthcare
LivaNova PLC（LIVN）のP/S比率
October 2026 時点のP/S比率 TTM: 2.84
LivaNova PLC の最新の財務報告および株価によると、現在のP/S比率（TTM）は 2.84 です。2023 年末時点でのP/S比率は 2.42 でした。
LivaNova PLC の P/S 比率の履歴（2000 ～ 2026）
各年末時点のP/S比率
| 年 | P/S比率 | 変化 |
|---|---|---|
| 2026 (TTM) | 2.84 | 42.01% |
| 2024 | 2.00 | -17.11% |
| 2023 | 2.42 | -16.82% |
| 2022 | 2.91 | -32.02% |
| 2021 | 4.28 | 24.15% |
| 2020 | 3.44 | 2.38% |
| 2019 | 3.36 | -16.06% |
| 2018 | 4.01 | 5.30% |
| 2017 | 3.81 | 110.23% |
| 2016 | 1.81 | -66.32% |
| 2015 | 5.37 | -29.20% |
| 2013 | 7.59 | -14.77% |
| 2012 | 8.91 | -13.53% |
| 2011 | 10.30 | -10.81% |
| 2010 | 11.55 | -10.97% |
| 2009 | 12.97 | -15.16% |
| 2008 | 15.29 | 12.20% |
| 2007 | 13.62 | -3.49% |
| 2006 | 14.12 | -13.13% |
| 2005 | 16.25 | 11.43% |
| 2004 | 14.58 | -1.13% |
| 2003 | 14.75 | -31.71% |
| 2002 | 21.60 | 0.00% |
| 2001 | 0.00 | -100.00% |
| 2000 | 26.35 | 0.00% |
同業他社のP/S比率
| 企業 | P/S比率 | P/S比率の差 | 国 |
|---|---|---|---|
| 3.82 | 34.67% |
US
|
|
| 2.78 | -1.95% |
IE
|
|
| 4.18 | 47.13% |
US
|
|
| 2.97 | 4.58% |
US
|
|
| - | - |
DE
|
